¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"threshold erythema dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • erythema multiforme bullosum
    ¹°Áý´ÙÇüÈ«¹Ý
  • erythema multiforme exudativum
    »ïÃâ´ÙÇüÈ«¹Ý
  • erythema nodosum
    °áÀýÈ«¹Ý
  • erythema nodosum leprosum
    ³ªº´°áÀýÈ«¹Ý
  • erythema nodosum migrans
    À̵¿°áÀýÈ«¹Ý
  • familial annulare erythema
    °¡Á·¼ºÀ±»óÈ«¹Ý, °¡Á·¼º°í¸®È«¹Ý
  • gyrate erythema
    À̶ûÈ«¹Ý
  • morbilliform erythema
    È«¿ª¸ð¾çÈ«¹Ý
  • necrolytic migratory erythema
    ±«»ç¿ëÇØÀ̵¿È«¹Ý
  • solar erythema
    Àϱ¤È«¹Ý
  • acceptable daily dose
    ÀÏÀÏÇã¿ë·®
  • average dose
    1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
  • air dose
    °ø±â¼±·®
  • absorbed dose
    Èí¼ö¼±·®
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • annular erythema
    °í¸®È«¹Ý
  • cold erythema
    ÇÑ·©È«¹Ý
  • congenital telangiectatic erythema
    ¼±Ãµ¸ð¼¼Ç÷°üÈ®ÀåÈ«¹Ý
  • diaper erythema
    ±âÀú±ÍÈ«¹Ý
  • diffuse erythema
    ±¤¹üÀ§È«¹Ý
  • erythema
    È«¹Ý
  • erythema allergicum neonatorum
    ½Å»ý¾Æ¾Ë·¹¸£±âÈ«¹Ý
  • erythema chronicum migrans
    ¸¸¼ºÀ̵¿È«¹Ý
  • erythema dyschromicum perstans
    Áö¼Ó»ö¼ÒÀÌ»óÈ«¹Ý
  • erythema elevatum diutinum
    Áö¼ÓÀ¶±âÈ«¹Ý
  • erythema exudativum multiforme
    ´ÙÇü»ïÃâÈ«¹Ý
  • erythema figuratum perstans
    Áö¼ÓÁöµµ¸ð¾çÈ«¹Ý
  • erythema gangrenosum
    ±«ÀúÈ«¹Ý
  • erythema induratum
    °æ°áÈ«¹Ý
  • erythema infectiosum
    °¨¿°È«¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • acceptable daily dose : ADD
    ÀÏÀÏÇã¿ë·®(ìéìíúÉé»Õá).
  • acceptable dose
    ¿ëÀμ±·®, ¼ö¿ë¼±·®, Çã¿ë¼±·®
  • adult dosage =a. dose
    ¼ºÀη®, ¼ºÀο뷮.
  • arbitrary dose
    ÀÓÀǿ뷮(ìòëòéÄåÖ).
  • fractional dose
    ºÐÇÒ·®.
  • genetic tolerance dose
    À¯ÀüÀû ³»·®(¡­Ò±åÖ).
  • given dose
    ¸í¸ñ¼±·®
  • gonadal dose
    »ý½Ä¼±¼±·®
  • half lethal dose
    ¹ÝÄ¡»ç·®(ÚâöÈÞÝåÖ).
  • head drop dose =HD
    µÎºÎ Ãß¶ô·®(¡­õÍÕªåÖ).
  • heat dose equivalent
    ¿­¼±·®´ç·®
  • high dose rate
    °í¼±·®À²
  • high dose rate intraluminal radiotherapy
    °í¼±·®À² °ü³»¹æ»ç¼±Ä¡·á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • relational threshold
    Â÷º°¿ªÄ¡.
  • renal threshold
    ½Å¿ªÄ¡(ãìÚ¤ö·), ÄáÆÏ¹®ÅÎ(°ª).
  • seizure threshold
    ¹ßÀÛ<°æ·Ã>¿ªÄ¡.
  • seizure threshold
    ¹ßÀÛ±ØÄ¡
  • seizure threshold
    ¹ßÀÛ<°æ·Ã>¿ªÄ¡(Û¡íÂ<ÌâÕý>¿ªÄ¡)
  • simultaneous spatial threshold
    µ¿½Ã¼º °ø°£¿ªÄ¡(¡­àõÍöÊàÚÊö·).
  • spatial threshold
    °ø°£Àû ¿ªÄ¡(¡­ÚÊö·).
  • speech reception threshold
    ¾îÀ½Ã»Ã뿪ġ(åÞëåôéö¢ÚÊö·).
  • speech reception threshold
    ¾îÀ½Ã»Ã뿪ġ
  • spike threshold
    ±ØÆÄ¿ªÄ¡
  • stimulus threshold
    ÀڱؿªÄ¡(ô§Ð½Ú¿ö·).
  • successive spatial threshold
    ¹Ýº¹¼º °ø°£ ¿ªÄ¡.
  • sugar threshold
    ´ç¿ªÄ¡.
  • swallowing threshold
    ¿¬ÇÏ¿ªÄ¡(æ¿ù»Ú¿ö·).
  • temporary threshold shift
    ÀϽÿªÄ¡º¯µ¿
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • minbimum lethal dose
    ÃÖ¼ÒÄ¡»ç·®(õÌá³öÈÞÝÕá)
  • permissible dose
    Çã¿ë·®(úÉé»Õá)
  • priming dose
    ÀÏÂ÷󸮿뷮(ìéó­ô¥×âéÄÕá)
  • radiation absorbed dose
    ¹æ»ç¼± Èí¼ö·®(Û¯ÞÒàÊýåâ¥Õá)
  • radiation dose
    ¹æ»ç¼±·®(Û¯ÞÒàÊÕá)
  • tissue culture infectious dose
    Á¶Á÷¹è¾ç °¨¿°·® (ðÚòÄÛÆå×ÊïæøÕá)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MID maximum inhibiting dilution; mesioincisodistal; midinfarct dementia; minimum infective dose; minimum...
NSD Nairobi sheep disease; neonatal staphylococcal disease; neurosecretory dysfunction; night sleep depr...
TCD tapetochoroidal dystrophy; T-cell depletion; thermal conductivity detector; tissue culture dose; tra...
MT magnetization transfer; malaria therapy; malignant teratoma; mammary tumor; mammilothalamic tract; m...
MPED minimum phototoxic erythema dose
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ADFT atrial defibrillation threshold
AFT Atrial fibrillation threshold
CFFT Critical Flicker Fusion Threshold
CPT Current Perception Threshold
DFT Defibrillation threshold
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • erythema multiforme postherpeticatium
    ´ë»ó Æ÷Áø ÈÄ ´ÙÇü È«¹Ý
  • erythema nodosum
    °áÀý È«¹Ý, °áÀý¼º È«¹Ý
    1. À¯Å뼺 È«»ö °áÀýÀ» Ư¡À¸·Î ÇÏ´Â ±Þ¼º ¿°Áõ¼º ÇǺΠÁúȯ. °¡Àå ÈçÇÏ°í ´ëÇ¥ÀûÀÎ °Ýº®¼º Áö¹æÃæ¿°. ¿øÀÎÀº Á¤È®È÷ ±Ô¸íµÇ¾î ÀÖÁö ¾ÊÀ¸³ª º£Å¸ ¿ëÇ÷¼º ¿¬¼â»ó ±¸±Õ °¨¿°, °áÇÙ, sulfonamide °èÅëÀÇ ¾àÁ¦¿Í °ü·ÃÀÌ ±í°í, µå¹°°Ô ³ªº´, ¿°Áõ¼º ´ëÀå Áúȯ ¹× ¾Ç¼º Á¾¾ç µî°úµµ µ¿¹ÝµÇ³ª ´ë°³´Â Ư¹ß¼ºÀÌ´Ù. Á÷°æ 1-5cmÀÇ È«¹ÝÀ» µ¿¹ÝÇÏ´Â ¾ÐÅ뼺 °áÀýÀÌ ÁÖ·Î Á¤°­ÀÌ¿¡ »ý±ä´Ù. 3-6ÁÖ°¡ Áö³ª¸é ÀÚ¿¬È÷ ¾ø¾îÁø´Ù. 2. ÁÖ·Î »çÃá±â¸¦ ÀüÈÄÇÑ ¿©ÀÚ¿¡°Ô ÀÖ´Â ÇǺκ´. ¾çÂÊ ´ëÅðºÎ¿¡ ¿ÏµÎ Å©±â ¶Ç´Â ´Þ°¿ Å©±â·Î »ì¦ µ¸¾Æ ¿À¸¥ È«»ö °áÀýÀÌ »ý±â´Âµ¥, »ó´çÈ÷ ´Ü´ÜÇÏ°í ´©¸£¸é ¾ÆÇÁ´Ù. º½°ú °¡À»¿¡ ¸¹ÀÌ »ý±â¸ç, Á¾Á¾ ¹ß¿­°ú °üÀýÅëÀÌ µû¸¥´Ù. ¼öÀÏ ¶Ç´Â ¸î ÁÖÀÏÀÌ Áö³ª´Â »çÀÌ¿¡ ¼­¼­È÷ ÀÛ¾ÆÁö°í, »öÁ¶µµ ¼±È«»ö, ¾ÏÈ«»ö, ÀÚ°¥»öÀ¸·Î ¹Ù²î¾î °á±¹ ¾ø¾îÁö´Âµ¥, °ò¾ÆÅÍÁö´Â ÀÏÀº ¾ø´Ù. ¾ÈÁ¤ÇØ¾ß Çϸç, ¼Ò¿°Á¦³ª Ç÷¾× ¼øÈ¯À» µ½´Â ³»º¹ ¾à µîÀÌ »ç¿ëµÈ´Ù.
  • erythema nodosum rheumatica
    ·ù¸¶Æ¼½º¼º °áÀý È«¹Ý
  • erythema simplex marginatum
    º¯¿¬¼º ´Ü¼ø È«¹Ý
  • erythema toxicum
    Áßµ¶¼º È«¹Ý
    ¾à¹° Áßµ¶ÀÇ °á°ú, ¶Ç´Â ¼¼±Õ¼º µ¶¼Ò ¹× ±âŸ µ¶¼º ¹°Áú¿¡ ÀÇÇØ¼­ ÀϾ¸ç Àü½Å¿¡ È®»êµÇ´Â È«¹Ý¼º ÇÇÁø ¶Ç´Â ¹ü¹ß¼º È«¹Ý¼ºÀÇ ¹Ý»ó ÇÇÁø.
  • erythema urticatum
    µÎµå·¯±â È«¹Ý
    µ¿ÀǾî=erythema urticans.
  • erythema variolosum
    µÎ⼺ È«¹Ý
  • erythema wheal reaction
    È«¹Ý ±¸Áø ¹ÝÀÀ
    ¾Ë·¹¸£±â¿øÀÇ °¨ÀÛ »óŸ¦ °Ë»öÇÒ ¸ñÀûÀ¸·Î ¾Ë·¹¸£±â¿ø ÃßÃâ¹°À» ÇǺΠǥ¸é¿¡ ÇÑ ¹æ¿ï ¶³¾î¶ß¸®°í ±× ¾×À» ÅëÇØ¼­ ÇǺΠǥ¸éÀ» ¹Ù´Ã·Î ±ÜÀ¸¸é À¯¸®µÇ´Â È­ÇÐ Àü´Þ ¹°Áú ¶§¹®¿¡ ÆØÁø ¹× È«¹ÝÀÌ ÃâÇöÇÑ´Ù. ¾Ë·¹¸£±â¿ø °Ë»çÀÎ °æ¿ì´Â ÆØÁø°æ ¶Ç´Â È«¹Ý°æÀÌ ´ëÁ¶ÀÇ 2¹è ÀÌ»ó, ȤÀº ±¸ÁøÀÇ Á÷°æÀÌ 5mm ÀÌ»óÀ» ¾ç¼ºÀ¸·Î ÇÑ´Ù.
  • inflammatory erythema
    ¿°Áõ¼º È«¹Ý
  • Jacquet's erythema
    ÀðÄÉ È«¹Ý
    ±âÀú±Í Àڱؿ¡ ÀÇÇØ À¯¾ÆÀÇ µÐºÎ¿¡ »ý±â´Â È«¹Ý.
  • ninthday erythema
    ±¸ÀÏ È«¹Ý
  • nodular erythema
    °áÀý¼º È«¹ÝÁõ
    ³ÐÀû ´Ù¸®ÀÇ ¹Ù±ùÂÊ, ÆÈÀÇ ÇǺγ» ¶Ç´Â ÇÇÇÏ¿¡ °­³²Äá ¶Ç´Â »õ¾Ë¸¸ÇÑ Å©±âÀÇ ´ãÈ«»ö ȤÀº ¼±È«»öÀÇ °áÀýÀÌ »ý±â´Â ÇǺκ´. ¹ß¿­, °üÀýÅë µîÀÇ Àü±¸ Áõ»óÀÌ ÀÖ´Ù. ·ù¸ÓƼ¼º, °áÇÙ¼ºÀÇ °ÍÀÌ ¸¹´Ù.
  • sharply delimited dedmatous erythema
    ¶Ñ·ÇÇÑ º¯¿¬ÀÇ ÁøÇǼº È«¹Ý
  • spotty erythema
    ¹ÝÁ¡¼º È«¹Ý
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
threshold of island of Reil The band of transition between the anterior portion of the gray matter of the insula and the anterior perforated substance; it is formed by a narrow strip of olfactory cortex along the lateral side of the lateral olfactory stria.
Synonym: threshold of island of Reil.
(05 Mar 2000)
threshold of nose A ridge marking the boundary between the nasal cavity proper and the vestibule.
Synonym: threshold of nose.
(05 Mar 2000)
threshold percussion Percussion effected by means of a glass rod as a plessimeter, the rod being inclined to the wall of the chest or abdomen and touching it only by one extremity.
(05 Mar 2000)
threshold shift Measurement of the degree of hearing loss or impairment in terms of a decibel shift from an individual's previous audiogram.
(05 Mar 2000)
threshold stimulus A stimulus of threshold strength, i.e., one just strong enough to excite.
See: adequate stimulus.
Synonym: liminal stimulus.
(05 Mar 2000)
threshold substance Any material (e.g., glucose) that is excreted in the urine only when its plasma concentration exceeds a certain value, termed its threshold.
Synonym: threshold body.
(05 Mar 2000)
threshold trait A trait that falls into natural groups that originate not in categorically distinct causes but in whether or not the outcome attains critical values; e.g., gallstones may result from a categorical cause or from unusual levels of causal factors that themselves show no evidence of grouping.
Synonym: liminal trait.
(05 Mar 2000)
transmission threshold <epidemiology> Occurs for a parasite when the basic reproductive rate Ro is equal to 1. Below this threshold level the disease is unable to maintain itself within the host population. Typically, for directly transmitted parasites there is a transmission threshold for the host population size.
(05 Dec 1998)
fibrillation threshold Least intensity of an electrical stimulus that will initiate fibrillation.
(05 Mar 2000)
fusion-inferred threshold test Employment of the phenomenon of cerebral fusion of binaural sounds to substitute for conventional masking in hearing testing.
Synonym: FIT test.
(05 Mar 2000)
light differential threshold The smallest difference in light intensity that can be appreciated.
(05 Mar 2000)
acrodynic erythema Pain in the extremities.
(12 Dec 1998)
macular erythema <paediatrics> Also called baby measles. This is a nonserious but common childhood viral infection that starts with a high fever and swollen lymph glands. After 24 hours, the fever breaks and the child develops a red rash on the neck and trunk.
(27 Sep 1997)
Milian's erythema An obsolete term for a nontoxic eruption that simulates measles or a toxic erythema, occurring usually on the ninth day of a course of medication; first described as a reaction to arsenical treatment of syphilis.
Synonym: Milian's disease, Milian's erythema.
(05 Mar 2000)
cold erythema Rash characterised by redness and itching, brought on by exposure to cold.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á